medline.ch Onkologie

	Progress and potential of ferritin nanocages for cancer drug delivery. Expert Opin Drug Deliv Giacobbo V, Gorgoglione F, Sevieri M, Bignami B, Tagliolini I, Corsi F, Mazzucchelli S. PMID: 41213168 [PubMed - as supplied by publisher]
	Periodontitis, Fusobacterium nucleatum, and Colorectal Carcinoma. A Review. Neuro Endocrinol Lett Straka M, Borecová P, Straka M. PMID: 41213144 [PubMed - as supplied by publisher]
	Early [18F]FDG PET/CT response after a single dose of anti-EGFR therapy as a predictive biomarker for treatment benefit in patients with advanced colorectal cancer. Clin Cancer Res Gerritse SL, Helden EJV, Arens AIJ, Boellaard R, Buffart TE, Labots M, Angus L, de Vries EGE, de Groot DJA, Pruijt HFM, Koornstra RHT, Hoekstra OS, Zwezerijnen GJC, Gootjes EC, Verheul HMW, Menke-van der Houven van Oordt CW. PMID: 41213105 [PubMed - as supplied by publisher]
	A phase II trial to evaluate the safety and immunogenicity of two doses of a folate receptor alpha vaccine in patients with triple negative breast cancer. Clin Cancer Res Knutson KL, Abu-Fares H, Keating P, Block MS, Norton N, Erskine CL, Cogen D, Assad H, Graff SL, Hamilton EP, Han HS, McIntyre KJ, Nassar A, Sparano JA, Tiersten A, Tkaczuk KH, Ward PJ, Wilson G, Garrett G, Kenney RT, Sharma P. PMID: 41213103 [PubMed - as supplied by publisher]
	Review of Large Language Models for Patient and Caregiver Support in Cancer Care Delivery. JCO Clin Cancer Inform Kouzy R, Cha EE, Rosen A, Bitterman DS. PMID: 41213099 [PubMed - in process]
	Utilization of Lung Cancer Registries in Learning Health Systems for Health Care Improvement. JCO Clin Cancer Inform Stirling RG, Baldwin DR, Heineman D, Wouters MWJM, Navani N, Dawkins P, Melder A, Zalcberg J, Jakobsen E. PMID: 41213098 [PubMed - in process]
	STROBE-Cross-Population Mendelian Randomization Analysis of Circulating Inflammatory Proteins and Cervical Cancer Risk in European and Asian Populations. Crit Rev Immunol Xian Z, Pang X. PMID: 41213068 [PubMed - in process]
	A multicenter dose-defining/expansion phase 1b study of first-line regorafenib plus pembrolizumab in patients with advanced hepatocellular carcinoma. Hepatology El-Khoueiry AB, Kim RD, Harris WP, Sung MW, Waldschmidt D, Cabrera R, Garosi VL, Ploeger BA, Zebger-Gong H, Brennan BJ, Wang YA, Mueller U, Weispfenning A, Seidel H, Coppieters S, Ishida TC, Galle PR. PMID: 41213032 [PubMed - as supplied by publisher]
	Community Nursing and Cancer Survivorship: A Matter of Appropriateness. Nurs Open Torreggiani M, Guberti M, Maselli D, Costi S. PMID: 41212943 [PubMed - in process]
	Expression and Clinical Significance of MMP-1 and MMP-7 in Pneumonia, Pulmonary Fibrosis, and Lung Cancer. J Vis Exp Wang C, Fan X, Fang S, Tan F, Zhang Y, Duan X, Hu H, Wang X. PMID: 41212837 [PubMed - in process]
	Prediagnostic dietary phytosterol intake, inflammatory biomarkers, and colorectal cancer survival: a cohort study. J Natl Cancer Inst Wu T, Ou Q, Xu H, Chen Y, Lin F, Fang Y, Zhang C. PMID: 41212775 [PubMed - as supplied by publisher]
	An early relapse prediction model based on pathological features following neoadjuvant immunotherapy for hepatocellular carcinoma. Oncologist Pang Y, Zhao X, Guo X, Han J, Ji Y. PMID: 41212769 [PubMed - as supplied by publisher]
	Gender-Stratified analysis of sepsis mortality in cancer: a 45-Year Population-Based cohort study. JNCI Cancer Spectr Guo Y, Lin Z, Zhang W, Chen H, Liu Y, Liu J, Zhang J, Zhang A, Mao S, Yao X. PMID: 41212764 [PubMed - as supplied by publisher]
	Prior-Radiomics-Guided Multi-Scale Feature Extraction Network Utilizing Preoperative MRI: A Pioneering Approach for Lymphovascular Invasion Prediction in Invasive Breast Cancer. Technol Cancer Res Treat He Y, Zuo Z, Li Y, Yang X, Feng Y, He L. PMID: 41212687 [PubMed - in process]
	Intrinsic capacity in community-dwelling older adults and cancer survivors: a comparative study. Eur Geriatr Med Bandeira ACL, Granai MVK, Almeida OLS, Peria FM, Andrade RF, Rapatoni L, Junior RCF, de Abreu DCC. PMID: 41212503 [PubMed - as supplied by publisher]
	Effects of polyphenols on cancer cell progression mediated by inhibition of cyclin-dependent kinases (CDKs): the emerging drug targets in cancer. Arch Pharm Res Basit A, Wen S, Wang S. PMID: 41212496 [PubMed - as supplied by publisher]
	Two Phase II Trials of Adavosertib, a Wee1 Inhibitor with Docetaxel or Carboplatin plus Pemetrexed in Non-small-cell Lung Cancer. Target Oncol Johnson ML, Dakhil SR, Beck JT, Sadiq A, Menon S, Mugundu GM, Chmielecki J, Spigel DR. PMID: 41212474 [PubMed - as supplied by publisher]
	The role of circadian genes in predicting immunotherapy response and survival outcomes in cancer patients. Discov Oncol Wu C, Li Q, Yuan Y, Liu J, Wan L, Wang R. PMID: 41212461 [PubMed - in process]
	Reassessing the Role of Hepatopancreatoduodenectomy in Advanced Biliary Tract Cancer: A Systematic Review and Single-Arm Meta-Analysis of Modern Case Series. Ann Surg Oncol Yasukawa K, Shimizu A, Kubota K, Notake T, Hosoda K, Sakai H, Hayashi H, Soejima Y. PMID: 41212458 [PubMed - as supplied by publisher]
	A review on the role of IL-6 in the onset and progression of nasopharyngeal carcinoma. Med Oncol Tao Y, He L, Wang B, Jiang M, Tang L, Luo J, Lin T, He Y. PMID: 41212457 [PubMed - in process]

Artikel 1 - 20 / 1857736

Seite 1 von 92887

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung